Green Thumb Industries (GTBIF) Free Cash Flow (2019 - 2026)
Green Thumb Industries (GTBIF) posted Free Cash Flow of $56.9 million for Q1 2026, down 24.54% on a QoQ basis from $75.5 million in Q4 2025, and up 28.31% year-over-year from $44.4 million in Q1 2025.
Green Thumb Industries (GTBIF) Free Cash Flow (2019 - 2026) Analysis & Trends
Green Thumb Industries' Free Cash Flow history runs 8 years deep, the most recent figure standing at $56.9 million for Q1 2026.
- Quarterly Free Cash Flow rose 28.31% year-over-year to $56.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $226.4 million (up 151.4% YoY) and the FY2025 annual result came in at $213.9 million, up 85.97% from the prior year.
- Free Cash Flow was $56.9 million for Q1 2026 at Green Thumb Industries, down from $75.5 million in the prior quarter.
- Across five years, Free Cash Flow topped out at $75.5 million in Q4 2025 and bottomed at -$46.1 million in Q2 2023.
- A 5-year average of $21.8 million and a median of $16.1 million in 2024 frame the typical range for Free Cash Flow.
- Annual changes were most pronounced in 2022 — Free Cash Flow slumped 107.19% — and 2025, when it jumped 37173.27%.
- Green Thumb Industries' Free Cash Flow stood at $10.7 million in 2022, then jumped by 223.46% to $34.7 million in 2023, then sank by 53.42% to $16.1 million in 2024, then soared by 367.48% to $75.5 million in 2025, then fell by 24.54% to $56.9 million in 2026.
- Business Quant data shows GTBIF's Free Cash Flow at $56.9 million in Q1 2026, $75.5 million in Q4 2025, and $56.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -208.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 291.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -373.37 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 363.70 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 348.40 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 144.40 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -38.00 Mn |
| 10 | Green Thumb Industries | 1.63 Bn | 1.29 Bn | 143.65 Mn | 56.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 56.94 Mn |
| Mar 31, 2026 | 56.94 Mn |
| Dec 31, 2025 | 75.46 Mn |
| Dec 31, 2025 | 75.46 Mn |
| Sep 30, 2025 | 56.57 Mn |
| Sep 30, 2025 | 56.57 Mn |
| Jun 30, 2025 | 37.44 Mn |
| Jun 30, 2025 | 37.44 Mn |
| Mar 31, 2025 | 44.38 Mn |
| Mar 31, 2025 | 44.38 Mn |
| Dec 31, 2024 | 16.14 Mn |
| Dec 31, 2024 | 16.14 Mn |
| Sep 30, 2024 | 29.64 Mn |
| Sep 30, 2024 | 29.64 Mn |
| Jun 30, 2024 | -101,000.00 |
| Jun 30, 2024 | -101,000.00 |
| Mar 31, 2024 | 69.31 Mn |
| Mar 31, 2024 | 69.31 Mn |
| Dec 31, 2023 | 34.66 Mn |
| Dec 31, 2023 | 34.66 Mn |